Do Combination Sildenafil/Tadalafil ED Medications Make Any Sense

Advocates say a drug to treat women’s sexual dysfunction is a start to addressing health inequity. Lee adds that recent bigger picture events, though, like the overturn of Roe v.

• Cost and insurance coverage are major practical hurdles, as off-label use is often not covered.
• The expense for daily or regular use can be prohibitive without approval.
• This limits access to comprehensive care that includes medication trials.

Wade and rollbacks on birth control access, have changed what health care looks like for women today.

Read next

The assessment included an online slide presentation followed by a comprehension test that proved the medical professionals knew and understood the drug’s risks of potential low blood pressure and fainting when combined with alcohol. Even further, patients had to sign a paper vowing not to drink while on the medication even though Cialis--another medication used to treat erectile dysfunction in men--creates similar interactions with alcohol but comes with no more than an advisement to moderate alcohol use. At the time of approval, the FDA argued that Addyi’s interaction with alcohol hadn’t yet been adequately studied. In 2019 and after additional research was conducted, the FDA modified its original alcohol warning for Addyi and removed the test requirement for doctors and pharmacists. In December of 2025, the FDA approved the drug for postmenopausal women, expanding access to more patients. The approval and acceptance of Addyi is part of a much larger and ongoing conversation about women’s health and regulatory policy currently. “The past five to 10 years really calls into question where the state of women’s health is going,” Lee said. The Pink Pill: Sex, Drugs & Who Has Control is streaming on Paramount+ in Canada and the U.S.

as of March 6, 2026.

Side Effects: How Do They Compare?

Also, your doctor will want “to make sure it's not related to your present situation or relationship. Because you can't fix HSDD if the problem is you really don't like your partner,” she says. Some insurance companies will cover HSDD medications. Your cost will vary based on your plan, but out-of-pocket cost for flibanserin is about $100 for 30 pills (1 month’s supply). Both drugs have different concerns and risks.

Report Problems to the Food and Drug Administration

The one you should take mostly depends on what works best for your lifestyle. “There are certainly women who have no interest in injections,” Volkar says. “Others have no interest in taking a pill every day.” It’s best to talk to your doctor about which one would work for you. Researchers have mainly studied how the medicines work in women who haven’t gone through menopause yet. So the FDA approved both drugs for premenopausal women only. Cialis lasts up to 36 hours, making it a long-acting option. Viagra works faster, with effects in 30 minutes, but lasts only about four hours. Cialis is also approved for treating an enlarged prostate and has fewer food restrictions.

• Viagra has been studied for its potential in treating female sexual arousal disorder with mixed outcomes.
• Cialis might improve blood flow to genital tissues, but its use for women remains experimental.
• These medications should not be used in women who are pregnant or breastfeeding without a doctor's approval.
• The placebo effect can play a role in perceived improvements in sexual function with these drugs.
• Psychological counseling and therapy can complement medication for comprehensive treatment of female sexual issues.
• Women with heart problems or on certain medications should avoid Viagra or Cialis due to health risks.
• Daily low-dose formulations are being explored as possible options for female sexual dysfunction.
• The presence of underlying hormonal imbalances could influence how women respond to these drugs.
• Most clinical trials focus on men; evidence for women is limited, requiring cautious application.
• Both Viagra and Cialis may cause side effects like dizziness, flushing, and visual disturbances in women.
• Proper diagnosis of female sexual dysfunction is vital before considering off-label use of these medications.
• Patients should seek medical advice to evaluate whether these drugs are appropriate for their specific situation.

Cialis and Viagra both work to treat erectile dysfunction, but they differ significantly in how long they last and when they start working.

While Cialis can last up to 36 hours, Viagra offers a quicker onset within 30 minutes.

• Sildenafil (Viagra) may help women with blood flow-related sexual dysfunction.
• Tadalafil (Cialis) offers a longer-lasting option but limited evidence for female use.
• Women should avoid these drugs if pregnant, breastfeeding, or with certain health risks.
• Medications may improve desire temporarily but do not address mental or hormonal causes alone.
• The gender-specific response to PDE5 inhibitors remains under investigation in clinical trials.
• Side effects such as headaches or nasal congestion are common in women taking these drugs.
• Use of these medications should be part of a comprehensive health evaluation.
• Psychological and relationship therapy should be considered for persistent issues.
• The European Medicines Agency has not approved these drugs for female sexual dysfunction.
• Personalized treatment approaches are more effective than one-size-fits-all solutions.
• Further advancement in female sexual medicine aims to develop targeted therapies.
• Women interested in these options should seek specialized medical advice.

Cialis (tadalafil) and Viagra (sildenafil) are both phosphodiesterase type 5 (PDE5) inhibitors used to treat erectile dysfunction (ED).

Which one lasts for longer?

Lee highlights that FDA choices and approvals are not just regulatory decisions, but that they also shape who can get care and how easily. “If you’re a cisgender, white male, health care in the United States is pretty darn good, and your health care experience can be a uniquely personal one,” she said. In other words, women and minority groups often don’t have a similar, positive experience. “FDA decisions are not just scientific determinations, but structural choices that shape access, risk, and who benefits from innovation,” said Lee. The FDA declined approval for Addyi in 2010 and 2013, with some critics referring to the treatment as “an ineffective drug for a nonexistent problem.” However, data from the University of Colorado Anschutz Department of Obstetrics and Gynecology shows that 10% of women across all age groups suffer from HSDD, which can “cause significant levels of personal distress.” To put it into perspective, HSDD is just as common as autoimmune disorders like rheumatoid arthritis, and in the U.S.

Comparison table

alone there are nearly a million patients taking oral medication to treat their autoimmune condition. Though HSDD is not a threat to physical wellbeing, both conditions can have significant impact on a person’s life. Like most medications, Addyi doesn’t work for everyone, but its availability gives women struggling with HSDD an option that otherwise doesn’t exist. Still, early research didn’t quite satisfy the FDA. “When the data first went up for review in 2010, the FDA did not feel that there was enough data to support Addyi’s effectiveness,” said Lee. They increase blood flow to the penis, which helps produce an erection suitable for sex.

• The effectiveness of Viagra in women may depend on underlying causes of sexual dysfunction.
• Cialis might help improve blood flow in women with sexual arousal disorders, but research is still inconclusive.
• Both drugs have potential interactions with other medications, such as nitrates or blood pressure drugs.
• There are no FDA-approved medications specifically for female sexual dysfunction like Cialis or Viagra.
• Psychological and emotional factors are often more significant in female sexual health than physiological ones.
• Some women report increased confidence and arousal with the use of these medications, but individual results differ.
• The cost of Cialis or Viagra can be significant and may not be covered by insurance for off-label use.
• The safety profile for women is less well-studied, making medical guidance crucial before use.
• Lifestyle factors like stress, relationship issues, and mental health are essential considerations alongside medication.
• Research into female-specific formulations of these drugs is ongoing, with some promising developments.
• Both drugs are taken orally, but the timing and dosage can affect their efficacy and side effects.
• Women should discuss all their health conditions and medications with a healthcare provider before trying these treatments.

A key difference between Cialis and Viagra is their duration of action, largely determined by their biological half-life.

The Biggest Practical Difference: Timing and Duration

Women who are pregnant or breastfeeding should not use either drug. There are others who shouldn’t take the medications, including those who: Take medication for HIV, hepatitis C, or high blood pressure that’s not under control “They can also interact with several drugs women commonly take, like fluconazole (Diflucan), which is a yeast infection medication, and also some antibiotics,” Volkar says. “So it's good to be aware of what medications you're on and discuss those with your doctor.” Women who use HSDD medications shouldn’t drink alcohol from 2 hours before they take the drug until the following morning, because it can lower blood pressure to dangerous levels. The drugs can cause side effects, such as: Bremelanotide can cause your skin and gums to get darker. To measure how well these drugs treat HSDD, doctors look at whether sexual desire has gone up and if distress about it has gone down.

Related Disease Conditions

Volkar says flibanserin typically leads to “one more sexually significant event per month.” That may sound like a success to some and not to others. “It depends on how you define things,” she says. “Is that awesome, or is that not so great? When I'm counseling a patient, I kind of leave that to their discretion and let them decide what that means for them.” There is no “normal” amount of sex or desire. So a change in the distress a woman feels about her sex drive is often a key sign of how well the treatment is working. This refers to the time it takes for drug levels in the bloodstream to drop by half.

What If Viagra or Cialis Is Not Enough?

The drug was originally tested in a clinical trial with over 2,000 premenopausal women either taking Addyi or a placebo pill. Participants taking Addyi were 10% more likely to report an increase in satisfying sexual events. A more recent study found that about half of women taking Addyi reported benefit to their sex life. Advocates for women’s health criticized the FDA’s early rejections and claimed gender bias, especially because Viagra was approved under an expedited priority review process, taking less than a year to achieve approval. Though the purposes of Addyi and Viagra are similar, Addyi corrects chemical imbalances of certain neurotransmitters in the brain that are responsible for sexual desire or excitement, which makes the drug approval process more complex.

Pros of Viagra

“Erectile dysfunction was seen as an unmet physical ailment,” said Lee. Because of that, Viagra was evaluated as treatment to address a physical need. HSDD 50mg viagra was not considered an unmet physical ailment in the eyes of the FDA but rather an unmet psychological ailment, which “immediately triggers a higher standard of review and additional safety measures,” Lee adds. While the drugs had to be evaluated differently, supporters of Addyi claimed that stigma and overly cautious FDA warnings deterred patient use even after it was approved. For example, doctors and pharmacists had to take a test, known as a Risk Evaluation and Mitigation Strategy assessment, to prescribe and administer Addyi. Cialis has a longer half-life than Viagra, leading to a longer duration of action: Cialis: Works up to 36 hours (giving it the nickname "the weekend pill") Viagra: Works up to around four hours, with the strongest effects seen in the first two hours PDE5 inhibitors prevent the breakdown of cyclic guanosine monophosphate (cGMP), which relaxes blood vessels and increases blood flow to the penis for stronger erections.

How Food Affects Effectiveness

If you try the medicine for 8 weeks and you haven’t felt a change, your doctor may recommend you stop taking it. The bottom line, Volkar says, is that though these treatments may not be perfect yet, having two medications available on the market is a move in the right direction. “I think it's great that we're finally doing research into medications for women and sexual desire,” she says. “I don't think it's quite the answer yet, but it’s an important first step.” While sexual dysfunction affects both men and women, men have 26 FDA-approved treatments to choose from. A new documentary explains that it’s in part because the FDA drug approval process determines which sexual health options are available, and how restrictions or labeling decisions can limit access for certain groups.

Top Cialis vs Viagra Related Articles

“When you look at women — premenopausal, postmenopausal, transgender individuals — the conversation of what is available to you is not dictated by you,” explains Johns Hopkins Carey Business School Law and Ethics Professor Stacey Lee in The Pink Pill: Sex, Drugs & Who Has Control. Addyi, or flibanserin, treats Hypoactive Sexual Desire Disorder, a common condition defined by lack of sexual desire in women. It has yet to achieve the same kind of widespread use or acceptance as men’s Viagra, which is used by millions of patients annually since its 1998 debut. The Pink Pill recounts the journey of Sprout Pharmaceuticals Founder and CEO Cindy Eckert, the entrepreneur buy generic viagra online whose company developed and brought Addyi to market, as she set out to expand access for sexual health treatments for women. Eckert’s path in developing Addyi for patient use was more of a struggle than it should’ve been, according to the documentary, which calls out the inequalities in availability of sexual health treatment between men and women.